Effects of estradiol with P4 vs MPA on risk markers BrCa

admin LL Breast Cancer

Compared to placebo, Estradiol and MPA(synthetics) resulted in significantly greater breast proliferation, while Estradiol and Progesterone (bio-identical) did not.  These findings suggest that oral (bio-identical) Progesterone has a more favorable effect on risk biomarkers for post-menopausal Breast Cancer than MPA alone/ thus Progesterone derivatives…could be more promising drugs against Breast Cancer.